Drug Trial Radar · NCT06620523
Prevent Cardiac Surgery Associated AKI Trial
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
242
Planned (sponsor's estimate)
Start
Jul 18, 2024
Primary completion
Jun 17, 2027
Study completion Jun 17, 2028
Sponsor
- Lead sponsor
- George Washington UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prevent CSA-AKI (Cardiac Surgery Associated Acute Kidney Injury) trial is a double blinded randomized controlled trial, 242 patients undergoing elective cardiopulmonary bypass surgery (CPB)will either receive a placebo or daily 1200 mg of Co enzyme Q10 (CoQ10) and 1000 mg of Glutathione (GSH), the first dose will be given the day before surgery and continues while admitted up to 1 week. Blood and urine samples will be collected. Adverse events related to the study drugs will be collected.
Conditions
- Renal Failure
- Coronary Artery Disease
- Surgery
- Surgery-Complications
Interventions
CoQ10 1200 mg orally with Glutathione 1000 mg orallyDrug
This is the intervention to assess efficacy of CoQ10 and Glutathione in prevention of cardiac surgery associated acute kidney injury
Group B: Placebo CoQ10 orally and Placebo Glutathione orallyDrug
A placebo to exactly match the CoQ10 will be made with white gelatin empty capsules containing cellulose AND a placebo to exactly match the L-Glutathione will be made with white gelatin empty capsules containing cellulose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- AKI incidence reductionTime frame: 28 days
- AKI incidence reductionTime frame: 90 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
George Washington University Hospital
Washington D.C., District of Columbia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.